Jump to Main Content
Rhamnogalacturonan I containing homogalacturonan inhibits colon cancer cell proliferation by decreasing ICAM1 expression
- Maxwell, Ellen G., Colquhoun, Ian J., Chau, Hoa K., Hotchkiss, Arland T., Waldron, Keith W., Morris, Victor J., Belshaw, Nigel J.
- Carbohydrate polymers 2015 v.132 pp. 546-553
- anticarcinogenic activity, antineoplastic agents, cell proliferation, colorectal neoplasms, enzymes, gene expression, heat, neoplasm cells, pH, pectins
- Pectin modified with pH, heat or enzymes, has previously been shown to exhibit anti-cancer activity. However, the structural requirements for modified pectin bioactivity have rarely been addressed. In this study several pectin extracts representing different structural components of pectin were assessed for effects against colon cancer cells. Rhamnogalacturonan I (RGI) extracts reduced proliferation of DLD1 and HCT116 colon cancer cells in a dose- and time-dependent manner. RGI reduced ICAM1 gene expression and siRNA-mediated knockdown of ICAM1 expression decreased cell proliferation providing a potential novel mechanism for the anti-cancer activity of pectin. Structural analysis of bioactive and non-bioactive RGIs suggested that a homogalacturonan component is maybe essential for the anti-proliferative activity, furthering the understanding of the structural requirements for pectin bioactivity.